NCT03003520 2023-05-22A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell LymphomaCelgenePhase 2 Completed46 enrolled 20 charts
NCT01497496 2021-04-27Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)H. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed29 enrolled 9 charts